Investigating a Novel Neurodegenerative Disease Toxic Mechanism Involving Lipid Binding Specificity of Amyloid Oligomers
ACS Chemical Neuroscience · 2024
DOI: 10.1021/acschemneuro.3c00830 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2024. Verfasst von Sarah S Hirschbeck und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Tennessee, Knoxville, Tennessee 37996, United States. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Crystallins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Eli Lilly and Company, Stauffer Summer Chemistry Endowment.
Abstract (Originalsprache)
Exploring the mechanisms underlying the toxicity of amyloid oligomers (AOs) presents a significant opportunity for discovering cures and developing treatments for neurodegenerative diseases. Recently, using a combination of ion mobility spectrometry-mass spectrometry (IMS-MS) and X-ray crystallography (XRC), we showed that the peptide KVKVLWDVIEV, which is the G95W mutant of αB-Crystallin (90-100) and abbreviated as G6W, self-assembles up to a dodecamer that structurally resembles lipid transport proteins. The glycine to tryptophan mutation promotes not only larger oligomers and enhanced cytotoxicity in brain slices than the wild type but also a narrow hydrophobic cavity suitable for fatty acid or phospholipid binding. Here, we determine the plausibility of a novel cytotoxic mechanism where the G6W's structural motif could perturb lipid homeostasis by determining its lipid binding selectivity and specificity. We show that the G6W oligomers have a strong affinity toward unsaturated phospholipids with a preference toward phospholipids containing 16-C alkyl chains. Molecular dynamics simulations demonstrate how an unsaturated, 16-C phospholipid fits tightly inside and outside G6W's hydrophobic cavity. This binding is exclusive to the G6W peptide, as other amyloid oligomers with different atomic structures, including its wildtype αB-Crystallin (90-100) and several superoxide dismutase 1 (SOD1) peptides that are known to self-assemble into amyloid oligomers (SOD1P28K and SOD1WG-GW), do not experience the same strong binding affinity. While the existing chaperone-lipid hypothesis on amyloid toxicity suggests amyloid-lipid complexes perforate cell membranes, our work provides a new outlook, indicating that soluble amyloid oligomers disrupt lipid homeostasis via selective protein-ligand interactions. The toxic mechanisms may arise from the formation of unique amyloid oligomer structures assisted by lipid ligands or impaired lipid transports.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Tennessee, Knoxville, Tennessee 37996, United States.
- Department of Chemistry, Westmont College, Santa Barbara, California 93108, United States.
ORCID-Profile: Thanh D Do
Förderung
- Eli Lilly and Company
- Stauffer Summer Chemistry Endowment
Zitieren
APA
Hirschbeck, S. S., Lindberg, E. T., Jang, J. H., Jacob, M. R., Lazar Cantrell, K. L., & Do, T. D. (2024). Investigating a Novel Neurodegenerative Disease Toxic Mechanism Involving Lipid Binding Specificity of Amyloid Oligomers. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.3c00830
Vancouver
Hirschbeck SS, Lindberg ET, Jang JH, Jacob MR, Lazar Cantrell KL, Do TD. Investigating a Novel Neurodegenerative Disease Toxic Mechanism Involving Lipid Binding Specificity of Amyloid Oligomers. ACS Chemical Neuroscience. 2024. doi:10.1021/acschemneuro.3c00830
BibTeX
@article{Hirschbeck2024,
author = {Hirschbeck, Sarah S and Lindberg, Edward T and Jang, Joshua H and Jacob, MaKenna R and Lazar Cantrell, Kristi L and Do, Thanh D},
title = {Investigating a Novel Neurodegenerative Disease Toxic Mechanism Involving Lipid Binding Specificity of Amyloid Oligomers},
journal = {ACS Chemical Neuroscience},
year = {2024},
doi = {10.1021/acschemneuro.3c00830}
}
EUVIMED